NM_015166.4(MLC1):c.135dup (p.Cys46fs) AND Megalencephalic leukoencephalopathy with subcortical cysts 1

Germline classification:
Pathogenic (7 submissions)
Last evaluated:
Feb 17, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000004987.19

Allele description [Variation Report for NM_015166.4(MLC1):c.135dup (p.Cys46fs)]

NM_015166.4(MLC1):c.135dup (p.Cys46fs)

Gene:
MLC1:modulator of VRAC current 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
22q13.33
Genomic location:
Preferred name:
NM_015166.4(MLC1):c.135dup (p.Cys46fs)
HGVS:
  • NC_000022.11:g.50084773dup
  • NG_009162.1:g.6162dup
  • NM_001376472.1:c.135dup
  • NM_001376473.1:c.135dup
  • NM_001376474.1:c.135dup
  • NM_001376475.1:c.135dup
  • NM_001376476.1:c.135dup
  • NM_001376477.1:c.135dup
  • NM_001376478.1:c.135dup
  • NM_001376479.1:c.135dup
  • NM_001376480.1:c.135dup
  • NM_001376481.1:c.135dup
  • NM_001376482.1:c.135dup
  • NM_001376483.1:c.135dup
  • NM_001376484.1:c.-59+587dup
  • NM_015166.4:c.135dupMANE SELECT
  • NM_139202.3:c.135dup
  • NP_001363401.1:p.Cys46fs
  • NP_001363402.1:p.Cys46fs
  • NP_001363403.1:p.Cys46fs
  • NP_001363404.1:p.Cys46fs
  • NP_001363405.1:p.Cys46fs
  • NP_001363406.1:p.Cys46fs
  • NP_001363407.1:p.Cys46fs
  • NP_001363408.1:p.Cys46fs
  • NP_001363409.1:p.Cys46fs
  • NP_001363410.1:p.Cys46fs
  • NP_001363411.1:p.Cys46fs
  • NP_001363412.1:p.Cys46fs
  • NP_055981.1:p.Cys46fs
  • NP_055981.1:p.Cys46fs
  • NP_631941.1:p.Cys46fs
  • NC_000022.10:g.50523196_50523197insG
  • NC_000022.10:g.50523202dup
  • NM_015166.3:c.135dup
  • NM_015166.3:c.135dupC
  • NM_015166.4:c.135dupCMANE SELECT
  • NM_139202.3:c.135dupC
  • NR_164811.1:n.482dup
  • NR_164812.1:n.266dup
  • NR_164813.1:n.659dup
Protein change:
C46fs
Links:
OMIM: 605908.0011; dbSNP: rs80358241
NCBI 1000 Genomes Browser:
rs80358241
Molecular consequence:
  • NM_001376472.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376473.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376474.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376475.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376476.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376477.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376478.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376479.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376480.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376481.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376482.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376483.1:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_015166.4:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_139202.3:c.135dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001376484.1:c.-59+587dup - intron variant - [Sequence Ontology: SO:0001627]
  • NR_164811.1:n.482dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_164812.1:n.266dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_164813.1:n.659dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1)
Synonyms:
Vacuolating megalencephalic leukoencephalopathy with subcortical cysts; Megalencephaly-cystic leukodystrophy; Leukoencephalopathy with swelling and cysts
Identifiers:
MONDO: MONDO:0024555; MedGen: C5779875; Orphanet: 2478; OMIM: 604004

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000025163OMIM
no assertion criteria provided
Pathogenic
(Aug 1, 2002)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000041274GeneReviews
no classification provided
not providedgermlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

SCV001194053Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019))
Pathogenic
(Dec 13, 2019)
unknownclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link,

SCV001573208Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicinheritedclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV003821540Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 17, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV003925691Lifecell International Pvt. Ltd
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV004194971Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 17, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedinheritedyesnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, literature only
Asiangermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation.

Gorospe JR, Singhal BS, Kainu T, Wu F, Stephan D, Trent J, Hoffman EP, Naidu S.

Neurology. 2004 Mar 23;62(6):878-82.

PubMed [citation]
PMID:
15037685

Megalencephalic leukoencephalopathy with subcortical cysts.

Singhal BS, Gorospe JR, Naidu S.

J Child Neurol. 2003 Sep;18(9):646-52. Review.

PubMed [citation]
PMID:
14572144
See all PubMed Citations (7)

Details of each submission

From OMIM, SCV000025163.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a patient of Indian Agrawali ancestry with megalencephalic leukoencephalopathy with subcortical cysts (MLC1; 604004), Ben-Zeev et al. (2002) identified a homozygous insertion of a cytosine at nucleotide 135 at exon 2 of the MLC1 gene. This resulted in a frameshift and the creation of a stop codon 104 bp downstream.

Leegwater et al. (2002) described this mutation in 3 Agrawali patients. They stated that the disease was probably introduced into the tribe by a single founder, and the mutation is probably shared by all MLC patients of this community.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000041274.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Myriad Genetics, Inc., SCV001194053.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

NM_015166.3(MLC1):c.135dupC(aka C46Lfs*34) is classified as pathogenic in the context of megalencephalic leukoencephalopathy with subcortical cysts. Sources cited for classification include the following: PMID 15037685, 14572144, 22006981, 12189496 and 11935341. Classification of NM_015166.3(MLC1):c.135dupC(aka C46Lfs*34) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India, SCV001573208.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedyesnot providednot providednot providednot providednot providednot providednot provided

From Revvity Omics, Revvity, SCV003821540.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Lifecell International Pvt. Ltd, SCV003925691.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Asian1not providednot providedclinical testing PubMed (2)

Description

A Homozygote Frameshift variant c.135dupC in Exon 2 of the MLC1 gene that results in the amino acid substitution p.Cys46fs*34 was identified. The observed variant has a minor allele frequency of 0.00003% in gnomAD exomes and and novel in 1KG, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease- causing. ClinVar has also classified this variant as Pathogenic [Variation ID: 4722]. The observed variation has been previously reported in individuals with megalencephalic leukoencephalopathy (Shukla P, et.al., 2011). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From Baylor Genetics, SCV004194971.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024